Takeda Pharmaceutical
TAK
#468
Rank
NZ$85.64 B
Marketcap
NZ$25.74
Share price
2.49%
Change (1 day)
12.86%
Change (1 year)

EPS for Takeda Pharmaceutical (TAK)

EPS in 2025 (TTM): NZ$0.92

According to Takeda Pharmaceutical's latest financial reports the company's current EPS (TTM) is NZ$0.97. a decrease over its 2024 EPS that were of NZ$0.53.

EPS history for Takeda Pharmaceutical from 2000 to 2025

Annual EPS

Year EPS Change
2025NZ$0.40-25.03%
2024NZ$0.53-60.3%
2023NZ$1.3326.77%
2022NZ$1.05-44.4%
2021NZ$1.89722.5%
2020NZ$0.23-79.14%
2019NZ$1.10-43.73%
2018NZ$1.9570.24%
2017NZ$1.1545.47%
2016NZ$0.79-158.86%
2015NZ-$1.34-217.99%
2014NZ$1.14-34.43%
2013NZ$1.735.17%
2012NZ$1.65-49.61%
2011NZ$3.27-6.27%
2010NZ$3.4936.82%
2009NZ$2.55-28.28%
2008NZ$3.5524.96%
2007NZ$2.849.24%
2006NZ$2.603.21%
2005NZ$2.52-6.29%
2004NZ$2.6918.8%
2003NZ$2.2730.39%
2002NZ$1.7452.45%
2001NZ$1.141.77%
2000NZ$1.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.12 1,759.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.43 560.22%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
NZ$2.99 206.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.77 1,211.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
NZ-$6.96-814.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$1.41 45.11%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
NZ$22.61 2,221.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.24 540.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$13.18 1,252.93%๐Ÿ‡บ๐Ÿ‡ธ USA